Genetic Disorder News and Research

RSS
Registry to help patients in need of bone marrow transplants

Registry to help patients in need of bone marrow transplants

Angelman Syndrome Foundation increases grant award for 2009 for AS research

Angelman Syndrome Foundation increases grant award for 2009 for AS research

Doris Duke Innovations award for sickle cell disease research

Doris Duke Innovations award for sickle cell disease research

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

UCLA discovery raises hope for curing genetic disorders caused by nonsense mutations

UCLA discovery raises hope for curing genetic disorders caused by nonsense mutations

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

European Commission grants conditional marketing authorization for Gilead's Cayston

European Commission grants conditional marketing authorization for Gilead's Cayston

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

A 2,000-mile scooter journey to raise cystic fibrosis awareness

A 2,000-mile scooter journey to raise cystic fibrosis awareness

'Pathway to a Cure' walk event in California

'Pathway to a Cure' walk event in California

SEQUENOM's first laboratory developed cystic fibrosis test launched

SEQUENOM's first laboratory developed cystic fibrosis test launched

Protein aggregation is linked to many conformational diseases

Protein aggregation is linked to many conformational diseases

Santaris Pharma establishes its operations in the U.S.

Santaris Pharma establishes its operations in the U.S.

Legislation grants improve research and employment initiatives in Indiana University medical campus

Legislation grants improve research and employment initiatives in Indiana University medical campus

Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results

Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results

Phase 3 trial of ataluren commences

Phase 3 trial of ataluren commences

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

Female insects control sperm storage to rule out genetic disorders

Female insects control sperm storage to rule out genetic disorders

Oxidative DNA damage: Primary cause of mutation

Oxidative DNA damage: Primary cause of mutation

FDA approves new xTAG Cystic Fibrosis 39 Kit v2 from Luminex

FDA approves new xTAG Cystic Fibrosis 39 Kit v2 from Luminex

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.